(Q37821853)

23 August 2017

1 reference

title

Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases (English)

1 reference

23 August 2017

1 reference

1 reference

1 reference

1 reference

1

0 references

Michael D'Angelica

series ordinal

2

object named as

Michael D'Angelica

1 reference

23 August 2017

Nancy E Kemeny

3

1 reference

23 August 2017

publication date

1 December 2010

1 reference

Journal of Surgical Oncology

23 August 2017

published in

1 reference

23 August 2017

volume

102

1 reference

23 August 2017

issue

8

1 reference

23 August 2017

page(s)

988-995

1 reference

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

23 August 2017

cites work

1 reference

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

21 January 2018

1 reference

Trends in long-term survival following liver resection for hepatic colorectal metastases

21 January 2018

1 reference

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

21 January 2018

1 reference

Anatomic variations of the hepatic arteries in 250 patients studied with 64-row CT angiography.

21 January 2018

1 reference

Laparoscopic hepatic artery catheterization for regional chemotherapy: is this the best current option for liver metastatic disease?

21 January 2018

1 reference

Laparoscopic placement of hepatic artery infusion pumps: technical considerations and early results.

21 January 2018

1 reference

Robotic-assisted placement of a hepatic artery infusion catheter for regional chemotherapy

21 January 2018

1 reference

Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases

21 January 2018

1 reference

Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases

21 January 2018

1 reference

Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model

21 January 2018

1 reference

Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

21 January 2018

1 reference

Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver.

21 January 2018

1 reference

A reversible enteropathy complicating continuous hepatic artery infusion chemotherapy with 5-fluoro-2-deoxyuridine

21 January 2018

1 reference

A new look at the arterial supply of the bile duct in man and its surgical implications

21 January 2018

1 reference

Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials

21 January 2018

1 reference

Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity

21 January 2018

1 reference

Alternating Hepatic Intra-Arterial Floxuridine and Fluorouracil: A Less Toxic Regimen for Treatment of Liver Metastases From Colorectal Cancer

21 January 2018

1 reference

Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma

21 January 2018

1 reference

Patterns of failure following curative resection of colorectal liver metastases

21 January 2018

1 reference

Hepatic arterial infusion after liver resection

21 January 2018

1 reference

Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study

21 January 2018

1 reference

Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

21 January 2018

1 reference

Actual 10-year survival after resection of colorectal liver metastases defines cure.

21 January 2018

1 reference

Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer

21 January 2018

1 reference

Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer

21 January 2018

1 reference

Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer

21 January 2018

1 reference

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases.

21 January 2018

1 reference

Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis

21 January 2018

1 reference

Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure

21 January 2018

1 reference

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

21 January 2018

1 reference

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

21 January 2018

1 reference

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

21 January 2018

1 reference

Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial

21 January 2018

1 reference

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

21 January 2018

1 reference

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study

21 January 2018

1 reference

Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.21753

1 reference

release_saz7skg7lrcerd5wn45hg4g5le

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/saz7skg7lrcerd5wn45hg4g5le

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference